Zenpep
Payments companies reported to CMS as associated with Zenpep. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zenpep, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zenpep
These are the largest totals companies reported as associated with Zenpep. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Meline | Scottsdale, AZ | Gastroenterology (Internal Medicine) | $268,667.43 |
| Arin Newman | Miami Beach, FL | Gastroenterology (Internal Medicine) | $247,908.55 |
| James Mckinnell | Torrance, CA | Infectious Disease | $247,734.27 |
| Jonathan Rosenberg | Gurnee, IL | Gastroenterology (Internal Medicine) | $155,947.81 |
| Nelson Royall | Gainesville, GA | Surgery | $114,043.62 |
| Carl Albers | Orange, CA | Gastroenterology (Internal Medicine) | $109,436.67 |
| Stuart Akerman | Plano, TX | Gastroenterology (Internal Medicine) | $104,999.06 |
| Omar Khokhar | Bloomington, IL | Gastroenterology (Internal Medicine) | $101,419.57 |
| Akshay Shah | Plymouth, MI | $91,432.47 | |
| Yoav Golan | Boston, MA | Infectious Disease | $78,265.51 |
Prescribed Zenpep?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.